Discovery and Development of Orally Bioavailable Peptides from Concept to Clinic is a PBSS symposium focused on the structural design, formulation development, translational science and intellectual property considerations involved in advancing peptide therapeutics. The program addresses the scientific and development challenges of achieving oral bioavailability for peptides, including permeability, stability, pharmacokinetics and formulation strategies.

Date: October 16, 2026
Location: Crowne Plaza Hotel, Foster City, California
Event Website: https://www.pbss.org/eventDetails/1058

JOIN US!

Learn how Catalent is advancing oral peptide drug development and delivery with modified release technology, bioavailability enhancement and scientific innovation. Meet with our experts to see how we can support your next breakthrough to bring better treatment to market and to patients.

Complete the form to schedule a meeting with our experts!

SPEAKING ENGAGEMENTS!

Speaker: Lisa Caralli, Sr. Director, Scientific Advisory
Date/Time: Friday, October 16 at 10:25am
Title: Better Together: Combining Medicinal Chemistry and Formulation Science for Oral Peptide Success

Oral peptide delivery is rapidly evolving as new formulation and drug delivery technologies expand the potential for therapies traditionally administered by injection. This presentation will explore how medicinal chemistry and formulation science work together to improve the oral delivery of peptides and how Catalent is helping drive innovation forward.

ABOUT CATALENT

Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that Catalent helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. Catalent provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. Catalent tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matter™